Show simple item record

dc.contributor.authorOprea, Gabriela E.
dc.contributor.authorKrober, Sandra
dc.contributor.authorMcWhorter, Michelle L.
dc.contributor.authorRossoll, Wilfried
dc.contributor.authorMuller, Stefan
dc.contributor.authorKrawczak, Michael
dc.contributor.authorBassell, Gary J.
dc.contributor.authorBeattie, Christine E.
dc.contributor.authorWirth, Brunhilde
dc.date2022-08-11T08:08:52.000
dc.date.accessioned2022-08-23T16:10:28Z
dc.date.available2022-08-23T16:10:28Z
dc.date.issued2008-04-29
dc.date.submitted2009-02-24
dc.identifier.citationScience. 2008 Apr 25;320(5875):524-7. <a href="http://dx.doi.org/10.1126/science.1155085">Link to article on publisher's site</a>
dc.identifier.issn1095-9203 (Electronic)
dc.identifier.doi10.1126/science.1155085
dc.identifier.pmid18440926
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32941
dc.description.abstractHomozygous deletion of the survival motor neuron 1 gene (SMN1) causes spinal muscular atrophy (SMA), the most frequent genetic cause of early childhood lethality. In rare instances, however, individuals are asymptomatic despite carrying the same SMN1 mutations as their affected siblings, thereby suggesting the influence of modifier genes. We discovered that unaffected SMN1-deleted females exhibit significantly higher expression of plastin 3 (PLS3) than their SMA-affected counterparts. We demonstrated that PLS3 is important for axonogenesis through increasing the F-actin level. Overexpression of PLS3 rescued the axon length and outgrowth defects associated with SMN down-regulation in motor neurons of SMA mouse embryos and in zebrafish. Our study suggests that defects in axonogenesis are the major cause of SMA, thereby opening new therapeutic options for SMA and similar neuromuscular diseases.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18440926&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1126/science.1155085
dc.subjectActins; Animals; Axons; Cell Differentiation; Cell Line; Cyclic AMP Response Element-Binding Protein; Female; Gene Expression; Growth Cones; Humans; Male; Membrane Glycoproteins; Mice; Microfilament Proteins; Muscular Atrophy, Spinal; Nerve Tissue Proteins; Pedigree; Phosphoproteins; RNA-Binding Proteins; SMN Complex Proteins; Spinal Cord; Survival of Motor Neuron 1 Protein; Transcription, Genetic; Zebrafish
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titlePlastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy
dc.typeJournal Article
dc.source.journaltitleScience (New York, N.Y.)
dc.source.volume320
dc.source.issue5875
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/1492
dc.identifier.contextkey738057
html.description.abstract<p>Homozygous deletion of the survival motor neuron 1 gene (SMN1) causes spinal muscular atrophy (SMA), the most frequent genetic cause of early childhood lethality. In rare instances, however, individuals are asymptomatic despite carrying the same SMN1 mutations as their affected siblings, thereby suggesting the influence of modifier genes. We discovered that unaffected SMN1-deleted females exhibit significantly higher expression of plastin 3 (PLS3) than their SMA-affected counterparts. We demonstrated that PLS3 is important for axonogenesis through increasing the F-actin level. Overexpression of PLS3 rescued the axon length and outgrowth defects associated with SMN down-regulation in motor neurons of SMA mouse embryos and in zebrafish. Our study suggests that defects in axonogenesis are the major cause of SMA, thereby opening new therapeutic options for SMA and similar neuromuscular diseases.</p>
dc.identifier.submissionpathgsbs_sp/1492
dc.contributor.departmentDepartment of Cell Biology
dc.contributor.departmentInstitute of Human Genetics
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages524-7


This item appears in the following Collection(s)

Show simple item record